116 funding opportunities are listed in this category
American Society of Hematology Visitor Training Program
The purpose of the Visitor Training Program (VTP) is to help build hematology capacity in developing countries, ultimately improving patient care and/or research. The VTP provides funding for hematologists, scientists, or laboratory staff working in hematology in developing countries to receive training on a specific topic or technique for up to 12 weeks. Training is carried out in a clinic or laboratory under the mentorship of an ASH member anywhere in the world. Upon completion of the training, participants return to their home institution to implement the training and share their newfound knowledge with their colleagues.Applications are now available for the 2010 Visitor Training Program.
Benefits * ASH will fund approved costs for travel and living expenses (applicants must submit a budget). * By implementing the training in their home institution, awardees will have the opportunity to increase hematology capacity for themselves and their colleagues, ultimately leading to improved patient care and/or research. * By training with an ASH member, the awardee will participate in the rigorous scientific community of ASH.Eligibility
Applicants * Physicians, scientists, and hematology laboratory staff working in a hospital or a research institution in one of the countries defined as developing by ASH are welcome to apply. * Applicants may be at any stage in their careers. * Applicants do not need to be ASH members.Application * The primary focus must be on specific training in procedures that will benefit the applicant’s home institution. * Relevant equipment and supplies must be available at the home institution. * The VTP is intended to build capacity. Participants must implement the training at their home institution upon their return. Individual research projects will not be considered. * Applications are reviewed by the ASH International Members Committee. Therefore, applications are not accepted from institutions where a member of the International Members Committee currently practices hematology.
For a current list of institutions, contact Clare Kelley at pckelley@hematology.org.Host institution and mentor * The host institution can be located anywhere in the world. * The host mentor may be from any country. * The host mentor must be a current ASH member in good standing on the day the application is submitted.DeadlinesApplication deadline: April 10, 2010Award notification: by July 15, 2010
Questions?If you have any questions or require any additional information regarding the ASH Visitor Training Program, please contact Clare Kelley, International Programs Specialist, at pckelley@hematology.org or 202-776-0544, ext. 4902.
American Society of Hematology2021 L Street NW, Suite 900 Washington, DC 20036Phone 202-776-0544 | Fax 202-776-0545
American Society of Hematology Scholar Awards
The ASH Scholar Awards are designed to support hematologists who have chosen a career in research by providing partial salary or other support during that critical period required for completion of training and achievement of status as an independent investigator. Eligibility Criteria (as of August 26, 2010)To be eligible for the Junior Faculty Scholar Award (either basic or clinical/translational research), applicants must be within the first three years of their initial faculty appointment as Assistant Professor at the time of application.To be eligible for the Fellow Scholar Award (either basic or clinical/translational research), applicants must have more than two years, but less than five years postdoctoral research training at the time of application. Applicants who are fellows must have completed their ACGME clinical year plus two full years (but no more than five) of postdoctoral research at the time of application.In addition to fellows, instructors, lecturers, and research associates should apply in the fellow category. The five-year maximum for postdoctoral research training also applies to these individuals. Applicants with these job titles are not yet eligible for the Junior Faculty Award.All Applicants: * Applicants must be an ASH member or have a pending application for membership. * Applicants must work in a U.S. or Canadian institution (such as a medical school, hospital, or research institute). An institution qualifies if it independently receives and administers grants and contracts from the National Institutes of Health. * Only one application per laboratory should be submitted per category (basic research fellow, basic research junior faculty, clinical/translational research fellow, and clinical/translational research junior faculty) for this competition. * Employees of the PHS at the NIH are not eligible for these awards as their salaries for research are covered under the terms of their employment. * Individuals with R01 grants or equivilant grants at the time of application are not eligible for these awards. Individuals with K awards from the NIH are eligible to apply. * At least 75 percent of the applicant’s full-time professional effort must be devoted to research.Application ProcessASH requires applicants to submit a letter of intent by May 1, 2010, in order to be eligible to submit a full proposal in August. The letter of intent should include the following: * Cover letter signed by applicant on institution letterhead (include mailing address, phone number, and e-mail address) * Abstract of proposed project, including title (please do not exceed 350 words) * Applicant's curriculum vitae * Identify which award category you plan to apply for: o Basic Research Fellow o Basic Research Junior Faculty o Clinical/Translational Research Fellow o Clinical/Translational Research Junior FacultyPlease e-mail your letter of intent to awards@hematology.org.ASH will perform a preliminary review of these materials to confirm eligibility and the appropriateness of the research category applied to. If additional information is required, ASH staff will contact you prior to June.The full ASH Scholar Award applications will be available in early June only for those individuals who successfully submit a letter of intent by the deadline and are confirmed to be eligible.Acceptance PolicyAnyone meeting the eligibility requirements set forth above can submit an application. The review of the scholar award applications is based solely on the scientific merit and quality of the applicant. However, in fairness to programmatic balance, no more than two awards will be granted per category (basic research fellow, basic research junior faculty, clinical/translational fellow, clinical/translational junior faculty) per medical school. For this purpose, ASH defines medical school so that it encompasses all sub-institutions (e.g., University of Washington would include the Fred Hutchinson Cancer Research Center, Children’s Hospital, etc.).Research SupportedBasic Research: ASH considers basic research to include a broad spectrum of studies on genes, proteins, lipids, carbohydrates, biochemical and signaling pathways, receptors, cells and animals, as well as samples obtained from humans, all of which are designed to further our understanding of the blood, bone marrow, and related organs or the pathogenesis of blood disorders. The emphasis for grants in this category should be on the discovery of new knowledge in a traditional laboratory setting.Clinical/Translational Research: ASH considers clinical/translational research to include translational research, patient-oriented research, and outcomes-based research. ASH emphasizes that clinical/translational research must involve substantial interaction with patients. * Translational Research For the purposes of the ASH Scholar Awards program, translational research means using knowledge of human biology to develop and test the feasibility of relevant interventions in humans and/or determine the biological basis for observations made in individuals with hematologic conditions or in populations at risk. Translational research should be founded on and directly connected to some aspect of human biology and may encompass any form of cellular, molecular, structural, biochemical, genetic, or other appropriate experimental approach. The proposal should address clinical applications – not just test development – although the development of novel instrumentation of value to hematology is clearly within the scope of the application.
* Patient-Oriented Research For the purposes of the ASH Scholar Awards program, patient-oriented research is defined as research conducted with human subjects and involves an investigator directly interacting with human subjects. Categories of patient-oriented research include: 1) mechanisms of human disease, 2) therapeutic interventions, 3) clinical trials, and 4) development of new technologies.
* Outcomes-Based Research ASH strongly encourages applications in outcomes-based research. Options for outcomes-based research include: 1) a decision-analysis or cost-effectiveness analysis of a relevant topic within hematology, 2) survey-based research investigating practice patterns, access to care, quality of care, clinical outcomes, or quality of life among patients with hematologic conditions, 3) retrospective analyses of large administrative databases (e.g., CMS, a large insurer, SEER) that may enlighten health care policy decisions related to hematologic disease, and 4) large scale epidemiologic or genetic epidemiologic studies that define the incidence, prevalence, prognosis, and natural history or the effects of therapy of blood disorders.Applications that fall within any of the categories discussed above are encouraged.SupportAwards are limited to a maximum of $100,000 for fellow scholars and $150,000 for junior faculty scholars over a two- to three-year period, with an annual maximum of $50,000 for fellows and $75,000 for junior faculty. Up to 15 percent of the award can be (but is not required to be) used for benefits, including medical and dental insurance, life insurance, and retirement benefits.All awards are activated on July 1 of the following year. The applicant has the option of concluding the award on June 30, two or three years after activation. All award payments are made on a quarterly basis – the amount depends on whether the award is being spread over two or three years. Payments are made to the appropriate financial officer of the institution as indicated on the proposed budget within the full application.General TimelineLetter of intent due Saturday, May 1, 2010Application available for those who successfully submit a LOI by the deadline June 2010Full proposal due Thursday, August 26, 2010Notification of awards Mid-NovemberActivation of award July 1, 2011
For more information about the ASH Scholar Awards program, please contact Elisa Shea, ASH Awards Manager, by e-mail or by phone at 202-776-0544.
American Society of Hematology2021 L Street NW, Suite 900Washington, DC 20036 Phone 202-776-0544 | Fax 202-776-0545
Scleroderma Foundation 2010 National Patient Education Conference Scholarships Available
Thanks to the generous support of many donors, scholarships will be available to the 2010 National Patient Education Conference in Boston, Massachusetts, July 31–August 1, 2010.Conference scholarships are intended for those who would be unable to attend without outside financial assistance. We regret we are unable to assist all those who apply for conference scholarships; however, the Foundation will use the resources of our scholarships funds to assist as many applicants as we are able.A patient-led committee will administer the award process based on available funds.The application deadline for is May 7, 2010.For more information, please contact Tracey O. Sperry, Director of Development and Research at 978-463-5843, ext. 44, or tsperry@scleroderma.org.
Reasons Why You Should Attend the 2010 National Patient Education Conference * Understand how to cope with the emotional challenges of having scleroderma * Develop strategies for staying motivated while living well with scleroderma * Meet people who want to take charge of their scleroderma, their health, and their lives * Build a support network you can turn to * Learn about current therapies from medical professionals * Talk with others who understand what you're going through * Become empowered through education to become a more effective partner in your own health care * Create public awareness to increase understanding * Decrease the feelings of isolation that can accompany the diagnosis of a chronic illnessWorkshops on the Hottest Topics on Scleroderma and Related Diseases * Pulmonary Hypertension * G.I. Involvement with Scleroderma * Raynaud's * Juvenile Scleroderma * Families and Scleroderma
Scleroderma Foundation, 300 Rosewood Drive, Suite 105, Danvers, MA 01923Phone: 978-463-5843 (8:30 a.m.–5:00 p.m. ET, Monday–Friday), Fax: 978-463-5809Toll-free: 800-722-HOPE (4673)
2010 Clinical Translational Research Career Development Awards in Pediatric Cancer
The Larry & Helen Hoag Foundation are currently accepting grant applications for the 2010 Clinical Translational Research Career Development Awards in Pediatric Cancer.Recipients will receive a maximum of $105,000 ($100,000 direct costs and $5,000 for institutional overhead expenses).
The purpose of the Clinical Translational Research Career Development Award in Pediatric Cancer is to support the development of outstanding clinician and translational investigators in pediatric cancer research. This mechanism provides support for specialized study by pediatric oncologists committed to a career in translational laboratory and clinical-based research. Candidates must have the potential to develop into independent investigators. The Award supports a three-year mentored research experience that integrates didactic studies with laboratory and clinically based research. The proposed research must have direct relevance to pediatric cancer, and the program must provide the experienced mentorship necessary to optimize the potential for the trainee to become a well-trained independent researcher. Basic eligibility criteria consists of the following: * Candidate must have a full-time faculty appointment at a U.S. Medical Institution or University and must be within 5 years of that appointment at the time of application. * Candidate must have either an M.D. or M.D/PhD degree. * Candidate must be sub-board eligible or certified in Pediatric Hematology-Oncology. * Applicants on a J-1 training visa are ineligible.Applications will be accepted on or before April 1, 2010.Notification of award will be made by June 1, 2010.Contact Rosa Lopez at roslopez@chla.usc.edu with any questions.
American Orthopaedic Society for Sports Medicine/Genzyme Osteoarthritis Grants
AOSSM, in partnership with Genzyme Biosurgery, is pleased to announce a new research grant program to fund investigations related to Early Osteoarthritis and/or Prevention of OA Progression. This grant program reflects growing recognition of the importance of osteoarthritis within sports medicine and orthopaedics. The program is an outgrowth of the Society’s conference on post-joint injury OA held in December 2008 and it underscores Genzyme’s long standing commitment to osteoarthritis research and therapy.
Two separate grants will be offered. One will provide $50,000 per year renewable, subject to annual progress review, for three years ($150,000 total) to support a clinical research study. The second will be a one-time award of $50,000 to support a lab/basic science project to separate investigators over successive three years. Proposed studies need not relate specifically to sports injuries and should also have broad applicability to OA in the general population. Projects involving viscosupplementation will not be considered for either grant. Applications will be reviewed for their potential impact on the field, the quality of study approach, and ability of investigator and site(s) to conduct and complete the proposed research.
The Principal Investigator on all applications must be an AOSSM member who has completed his or her training. It is expected that grantees will submit the results from their funded study to AOSSM for podium presentation and to AJSM for publication. The submission deadline for both the clinical and basic science grants is August 1st, 2010. Award notices will be made on or after October 15th with a start date of January 1, 2011. Inquires can be directed to Bart Mann, AOSSM Director of Research, bart@aossm.org
American Orthopaedic Society for Sports Medicine 6300 N. River Road Suite 500| Rosemont, Illinois 60018 (847) 292-4900
J. Patrick Barnes Grants for Nursing Research and Evidence-Based Practice Projects Patrick was a very inquisitive person by nature. He loved to collect information, and you never knew when or how he would use it constructively in a discussion. (Not to mention the fact that he was a whiz at Trivial Pursuit!) So it is fitting in his memory to support nurses in the clinical application of their own inquisitiveness to benefit patient care. PROGRAM GOALS For the Foundation: Funding research and evidence-based practice projects links our yearning to impact treatment of patients with auto-immune diseases and cancer and our passion for the compassionate work nurses do in medical facilities all over the country. For Nurses: This program provides support for nurses who Continually evaluate their practice Seek answers to clinical questions in an effort to improve their practice Change their practice based on evidence and evaluation of that change For Patients With Auto-Immune Diseases and Cancer: Nurses will improve care outcomes as a result of their findings! GENERAL GUIDELINES To be eligible, you must be a registered nurse with a current license Applicants should be ready to implement their projects immediately following funding from The DAISY Foundation. Only projects approved by your IRB or which have been exempted in writing by your IRB will be considered. A copy of your IRB approval will be required prior to our funding your grant. (You may, however, apply for a grant while IRB approval is pending.) Funds may be used only for direct expenses, including: Printed materials for study Small equipment Supplies (including software) Subject compensation to participate in the study Consultant fees up to $500, if justified Funds may not be used for salaries or institutional overhead Checks will only be written to your institution or a specified fund at your institution, not to an individual investigator.
PROJECT FOCUS Research must impact patients or family members of patients with an auto-immune disease or cancer. Studies that will benefit patients both within and outside of your institution will receive priority. If your study's demographics do not include a significant percentage of patients with an auto-immune disease or cancer, it will not qualify. APPLICATION PROCESS AND TIMING This year, all application materials will be submitted on-line. Each Applicant will be required to submit a Letter of Intent prior to the full grant proposal. The DAISY Foundation’s Grant Panel will review the Letters of Intent to ensure they follow essential grant guidelines. Applicants will be informed whether or not they should proceed to a full application. If the Grant Panel has any questions about your study, we will contact you for clarification. There will be two application cycles, so you may choose to follow either of the following time lines: CYCLE 1 DUE DATE Letters of Intent to be submitted on-line Friday, April 2nd, 2010 Applicants will be informed of the acceptance or denial of their Letters of Intent Friday, April 23rd, 2010 Complete grant applications to be submitted on-line Friday, May 28th, 2010 Applicants to be informed whether or not their proposal will be funded Wednesday, June 30th, 2010 CYCLE 2 DUE DATE Letters of Intent to be submitted on-line Friday, September 3rd, 2010 Applicants will be informed of the acceptance or denial of their Letters of Intent Friday, September 24th, 2010 Complete grant applications to be submitted on-line Friday, October 29th, 2010 Applicants to be informed whether or not their proposal will be funded Friday, December 10th, 2010 Please note that funding in the second cycle is subject to funds remaining in The DAISY Foundation’s grant budget. GRANT AWARDS AND GUIDELINES Two types of grants are available, as described below. Evidence-based Practice Grants (up to $2,000) These will be awarded to stimulate the use of patient-focused data and/or previously generated research findings to develop, implement and evaluate changes in nursing practice in treatment of patients with cancer and auto-immune diseases. We encourage nurses who have research/EBP experience as well as those who do not to apply. Funds for Evidence-Based Practice projects may be awarded for new projects, projects in progress, and projects required for an academic degree as long as all other project criteria are met. Eligible projects may include research utilization studies, continuous quality improvement projects, performance improvement initiatives, or outcomes evaluation projects. Interdisciplinary and collaborative projects are encouraged and may involve interdisciplinary teams, multiple nursing units, home health, sub-acute and transitional care, other institutions or community agencies. The Project Leader/Team Leader must be a nurse who is currently employed or formally affiliated with a clinical setting with direct patient care involvement. A Project Mentor is strongly recommended for each EBP grant application. We encourage Applicants to find a Mentor in your own institution, nearby school of nursing, or community. If you desire a Mentor and are unable to find one, The DAISY Foundation will provide time-limited mentor support. Mentors will provide the following benefits which will be especially helpful for less experienced Applicants: Help potential DAISY Grant Applicants become familiar with resources and problem-solve grant issues or concerns Advise and refer Applicants to appropriate internal and external resources Establish availability by phone or email to Applicants Review grant application and provide feedback/guidance as needed Your Mentor should be an established Advanced Practice Nurse who provides support to in the development and submission of an evidence-based practice grant. Mentors will assist Applicants in the development of the grant application, serving as a coach and advisor to the Mentee. Research Grants (up to $5,000) The Research Grant provides awards to qualified individuals carrying out clinical research studies that directly benefit patients and/or families involving treatment of cancer and auto-immune diseases. The Principal Investigator (PI) must be currently employed or formally affiliated with a clinical setting with direct patient care involvement. Funds may be awarded for new projects, projects in progress, and projects required for an academic degree as long as all other project criteria are met. As with EBP projects, we encourage you to identify a Mentor, especially if you are less experienced in applying for a research grant. If you desire a Mentor and are unable to find one, The DAISY Foundation will provide time-limited mentor support. With both EBP and Research grants, we will fund only direct expenses. We will not pay for institution overhead, fees to institutional review boards, Applicants’ time, etc. SUBSEQUENT GRANTS TO SUCCESSFUL APPLICANTS TO DISSEMINATE STUDY FINDINGS (UP TO $2,000) The DAISY Foundation will help successful Grantees share the results of their findings with other nurses and institutions. Therefore, final research reports will be posted on The DAISY Foundation’s web site. For the first time this year, once funded EBP projects and Research studies are underway, Grantees may apply for subsequent funding to present findings at professional conferences. These subsequent grants will provide up to $2,000 for Fees to present at a professional conference Travel expenses to the conference Poster production Funds will only be provided to Grantees whose projects have been approved for presentation by a professional conference. A separate application will be provided to Grantees to submit for this funding. THE APPLICATION PACKAGE As mentioned above, all materials will be provided to The DAISY Foundation electronically through its web site. Should you have any questions or problems completing the forms, please email bonniebarnes@DAISYfoundation.org. Applicants will complete the following forms: A fact sheet about the Applicants, your study, and your Mentor, if you will have one. A detailed Proposal for either your EBP project or your Research study (There are different forms for EBP and Research projects, so please choose the correct one for your study.) You will upload the following: Study timeline Detailed budget Letters of Support 1 is required from your Chief Nursing Officer or other appropriate institution leader No more than 2 additional letters of support may be submitted - only if they are relevant to your proposal (e.g. if outside organizations are involved, you may provide a letter from the organizations' leadership) Attachments such as Consent Forms Interview formats, discussion guides, etc. Other documents you feel important to our evaluation of your proposal For Research grants, Applicant’s CV For EBP grants, Applicant’s resume or CV A signed Letter of Agreement is required for your grant application to be considered. A copy of this Letter of Agreement follows the Evidence-Based Practice and Research Grant Fact Sheet and Proposal forms. Please copy and paste it onto your institution’s letterhead, complete and sign it. Then, scan it into your computer, and email it to bonniebarnes@DAISYfoundation.org. Only applications with this signed Letter of Agreement will be considered complete and ready for consideration by the Grant Panel. Proof of your Institutional Review Board (IRB)’s approval is needed prior to The DAISY Foundation’s actually funding your project. If a project is exempt from IRB approval, proof of that exemption is required. IF YOUR GRANT IS FUNDED... Interim and Final Reports At the half-way point and/or conclusion of your study (as described above), please plan to submit the following: Summary of project objectives Summary of findings Recommendations as result of study Financial summary Check for any unused funds Please email interim and final reports to bonniebarnes@DAISYfoundation.org. Publishing Your Research If you receive funding from us, please recognize The DAISY Foundation upon publication/presentation of your research in the following way: Funding provided by The DAISY Foundation’s J. Patrick Barnes Grant for Nursing Research and Evidence-Based Practice Projects (www.DAISYfoundation.org) A DAISY Foundation logo will be provided for your use. We will post the findings of your study on our web site and will discuss with you the specifics prior to our doing so.
The DAISY Foundation PO Box 788 Glen Ellen, CA 95442 For The DAISY Award in the U.S. Eastern and Central time zones, please contact Tena Barnes Carraher, Vice President, Co-founder (678) 364-0683 tenabarnescarraher@DAISYfoundation.org For The DAISY Award In the Pacific and Mountain time zones for international assistance, and for all other programs, please contact Bonnie Barnes, President, Co-founder (707) 996-7936 bonniebarnes@DAISYfoundation.org
Marcia C. Liebman New Writer Excellence AwardPurpose: To recognize and reward a new nurse author for excellence in the authorship of an article that contributes to the oncology nursing literature. The award will consist of $1,000 and a certificate, presented to and accepted by the first author on behalf of the writing/research team. These papers will be acknowledged at the annual ONS Congress in the compendium of awards, honors, and other special recognitions produced and distributed annually by ONS.Eligibility for ConsiderationA published article is eligible for nomination for the Marcia C. Liebman New Writer Award if 1. It meets general nomination criteria with the following exception: The first author must be a nurse who has never published before in a peer-reviewed journal. This criterion will be confirmed by literature search. 2. The article may appear in ONF or CJON and be either a scholarly article or a research report. 3. Papers prepared as part of the CJON Mentor/Fellow Writing Program are not eligible to receive this award.Judging Criteria 1. The subject is original, timely, and directly connected to a body of scientific and theoretical literature related to oncology nursing practice. 2. The article is clearly written and flows well; it creatively and appropriately includes tables, figures, illustrations, and photographs 3. The article provides comprehensive and up-to-date information about the subject in a readable format. 4. The article can be appreciated by a wide range of oncology nurse readers. 5. Authors articulate the significance of the issue to oncology nursing practice.Application deadline: December 1, 2010, 5pm (ET)
Oncology Nursing Society 125 Enterprise Drive Pittsburgh, PA15275866-257-4ONS (866-257-4667) 412-859-6100 877-369-5497 (toll free fax)412-859-6162 (fax)
Susan Baird Excellence in Clinical Writing AwardPurpose: To recognize and reward excellence in authorship of a paper that advances oncology nursing. The award will consist of $1,000 and a certificate, presented to and accepted by the first author on behalf of the writing team. These papers will be acknowledged at the annual ONS Congress in the compendium of awards, honors, and other special recognitions produced and distributed annually by ONS. Eligibility Criteria for NominationA published article is eligible for nomination for the Susan Baird Excellence in Writing Award if it 1. Meets general nomination criteria. 2. Is a clinical presentation of content on a subject that includes, but is not limited to, a drug or class of drugs; a specific cancer diagnosis; symptom management; topics related to the physical, psychological, spiritual, or social care of patients with cancer; genetics; prevention/detection; research methodology; ethics; or nurse (profession)-oriented topics. 3. Is not a report of research.Judging Criteria 1. The subject is original, timely, and directly connected to a body of scientific and theoretical literature related to nursing. 2. The article is clearly written and flows well; it creatively and appropriately includes tables, figures, illustrations, and photographs 3. The article provides comprehensive and up-to-date information about the subject in a readable format. 4. The article can be appreciated by a wide range of oncology nurse readers. 5. Authors articulate the significance of the issue to oncology nursing practice.Application deadline: December 1, 2010, 5pm (ET)
Oncology Nursing Society Clinical Lectureship
Award: A $2,000 honorarium, one coach airfare to ONS Annual Congress, two-day per diem for Congress, and a plaque. The paper is published in the September issue of the Oncology Nursing Forum.Purpose: To recognize and support excellence in clinical nursing practice. The lecture is presented at the ONS Annual Congress.Nominee's Eligibility Criteria:The candidate must meet the following criteria: * Be a registered professional nurse and an active ONS member * Have a minimum of two years experience in oncology nursing * Be a recognized expert in clinical nursing practice because of his or her contributions to the development of oncology nursingCriteria: The scoring criteria for judging this nomination packet is as follows: * ONS involvement: Participation should include involvement at the local or national level, and includes membership on committees, holding office, or task force participation. * The nominee's clinical practice is consistent with the ONS Scope of Oncology Nursing Practice and demonstrates the use of the following criteria: o Use of theoretical concepts o Use of the nursing process o Professional development of self and other o Multidisciplinary collaboration o Quality assurance o Uses ethical decision making o Reviews and applies research into practice (Examples of actual patient contacts, examples of actual patient experiences provided by patients within the reference letters, Clinical practice nursing research, Topics, lectures, a model or theory, developed standards of care, published a model/theory) * The nominee is an effective communicator: o Examples within reference letters o Presentations listed on CV well written based on the conference * Clinical practice contribution to literature: Includes articles in newsletters, journals, reports, video, multimedia, computer assisted instruction, or chapters in books * Contribution to the development of the oncology nursing practice: o Examples within reference letters or on CV o Clinical developments such as staff development, program development, patient teaching, support groups o Community outreach (Programs such as ACS, Leukemia Society, camps for patients with cancer, survivor's day participation or other related activities o Adjunct faculty or preceptor of students) * The clinical topic is relevant to membership at large, well written, concerns a current educational need and/or new trend.Application deadline: August 16, 2010, 5pm (ET).
Mary Nowotny Excellence in Cancer Nursing Education AwardAward: Monetary award of $1000 and a plaque.Purpose: This award is named in memory of Dr. Mary Nowotny, an active ONS member and past chair of the ONS Education Committee. She was a cancer-education advocate throughout her career and a widely published author, writing many articles on the measurement and significance of hope in patients with cancer. The Mary Nowotny Excellence in Cancer Nursing Education award recognizes and supports excellence in cancer nursing education.Nominee's Eligibility Criteria:The candidate must meet the following criteria: * Be a registered professional nurse and an active ONS member * Have a minimum of two years experience in oncology education * Be an educator who is a recognized expert in cancer education because of his or her contributions to cancer education at the local, state, national, or international level .Criteria: The scoring criteria for judging this nomination packet is as follows: * Be an educator whose teaching in cancer education programs is consistent with the ONS/American Nurses Association Statement on the Scope and Standards of Oncology Nursing Practice and has basis in the ONS Standards of Oncology Nursing Education * Educator has made contributions to cancer education at the local, state, national, or international level. * Educator has, in implementing cancer education programs, met the identified needs for cancer nursing education in his or her geographical area. * Educator implements programs that are well developed with clearly stated objectives. * Content of programs is relevant to current cancer nursing practice and is well presented. * Educator uses relevant and appropriate evaluation methods. * Educator is knowledgeable in the content area, establishes a positive teacher-learner relationship, and promotes and supports cancer education * Educator is supportive of and contributes to the development of professional oncology nursing practice.Application deadline: August 16, 2010, 5pm (ET).
For more information on any of the ONS awards, contact ONS at customer.service@ons.org. Both nominees and nominators will be notified once an application is received.Oncology Nursing Society 125 Enterprise Drive Pittsburgh, PA15275866-257-4ONS (866-257-4667) 412-859-6100 877-369-5497 (toll free fax)412-859-6162 (fax)
123456789101112next
